This study will evaluate the effectiveness and safety of an investigational product (IP), intravenous (IV) ganaxolone, to treat participants with status epilepticus (SE).
- Investigator
- Carolina B Maciel
- Ages
- 12 Years - N/A
- Sexes
- All
Clinical trials
-
RAISE -
Panafina RABI-767-201 The goal of this clinical trial is to test the safety and effectiveness of a single dose of RABI-767 given by endoscopic ultrasound (EUS) guided peripancreatic injection in participants with predicted severe acute pancreatitis. The main question the…
- Investigator
- John G Lieb
- Ages
- 18 Years - 85 Years
- Sexes
- All